GLP-1 Research
Ozempic is a GLP-1 receptor agonist containing semaglutide, a synthetic gut hormone analog that suppresses appetite, regulates blood…
Up to 45% of weight lost on semaglutide can come from skeletal muscle — here's what the latest…
Ozempic face is a real and increasingly well-documented phenomenon — here's the science behind why it happens and…
New research shows GLP-1 receptor agonists significantly reduce creatinine-linked kidney endpoints — here's what the data means for…
New clinical trial data shows semaglutide reduced biological age by up to 4.9 years on validated epigenetic clocks…
Artificial sweeteners do not meaningfully stimulate GLP-1 release under real-world conditions, and understanding why matters for anyone serious…
A complete guide to the tirzepatide dosage escalation schedule — from the 2.5 mg starting dose to 15…
Research shows that combining power walking with semaglutide significantly improves fat loss outcomes and helps preserve lean muscle…
A science-backed breakdown of the correct Ozempic dosage schedule, what the clinical trials say about dose and outcomes,…
GLP-1 medications can cause men to lose 10% or more of their muscle mass during treatment — here's…